Valerie Paradiz
Executive Director
Autistic Global Initiative
From this contributor
Tech tools help parents, teachers overcome autism’s hurdles
Web-based courses and online counseling can help families and service providers better understand the needs of individuals on the spectrum.
Tech tools help parents, teachers overcome autism’s hurdles
New programs let adults with autism find meaningful work
Employment is a crucial part of independent adult life, but many with autism struggle to find it.
New programs let adults with autism find meaningful work
Mother-son duo with autism bond through their differences
It took me a while to see that my son had autism. Only then did I recognize the autism in myself.
Mother-son duo with autism bond through their differences
Young adults with autism flounder in face of service gaps
A dearth of job-training programs and other services means that many young adults with autism struggle to lead productive, independent lives, suggests a national report.
Young adults with autism flounder in face of service gaps
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.